Part X. Tetracycline and glycylcycline antimicrobials.
Vincent
Simi
S
Infectious Diseases Section, PO Box 26901, WP 1160, Oklahoma City, OK 73190, USA.
Bronze
Michael S
MS
Cooper
Travis W
TW
Greenfied
Ronald A
RA
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D017920:Antiporters / Q000235:genetics; D001424:Bacterial Infections / Q000188:drug therapy*; D001426:Bacterial Proteins / Q000235:genetics; D004318:Doxycycline / Q000494:pharmacology; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects; D006801:Humans; D008911:Minocycline / Q000031:analogs & derivatives / Q000494:pharmacology; D011500:Protein Synthesis Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D013752:Tetracycline / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D013753:Tetracycline Resistance; D013754:Tetracyclines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D000078304:Tigecycline
D000900:Anti-Bacterial Agents; D017920:Antiporters; D001426:Bacterial Proteins; D011500:Protein Synthesis Inhibitors; D013754:Tetracyclines; C079051:tetA protein, Bacteria; C087533:CL 331002; D000078304:Tigecycline; D013752:Tetracycline; D008911:Minocycline; D004318:Doxycycline